Technical Analysis for LBPH - Longboard Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 11.63 -6.51% -0.81
LBPH closed down 6.51 percent on Friday, April 16, 2021, on 31 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical LBPH trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Hot IPO Pullback Bullish Swing Setup -6.51%
Lower Bollinger Band Walk Weakness -6.51%
Older End-of-Day Signals for LBPH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. The company was founded in 2020 and is based in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Neuroscience Neurology Epilepsy Psychiatry Amyotrophic Lateral Sclerosis Nervous System Clinical Trial Product Neurophysiology

Is LBPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.95
52 Week Low 11.59
Average Volume 43,469
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 15.26
10-Day Moving Average 14.23
Average True Range 1.24
ADX 0.0
+DI 10.40
-DI 26.91
Chandelier Exit (Long, 3 ATRs ) 15.23
Chandelier Exit (Short, 3 ATRs ) 15.31
Upper Bollinger Band 18.88
Lower Bollinger Band 11.63
Percent B (%b) 0.0
BandWidth 47.53
MACD Line -1.57
MACD Signal Line -0.79
MACD Histogram -0.7801
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.13
Resistance 3 (R3) 13.30 12.96 12.88
Resistance 2 (R2) 12.96 12.58 12.88 12.80
Resistance 1 (R1) 12.30 12.35 12.13 12.13 12.71
Pivot Point 11.96 11.96 11.88 11.88 11.96
Support 1 (S1) 11.30 11.58 11.13 11.13 10.55
Support 2 (S2) 10.96 11.35 10.88 10.46
Support 3 (S3) 10.30 10.96 10.38
Support 4 (S4) 10.13